The legal industry is currently witnessing a transformative shift as elite practitioners move away from traditional Big Law structures to embrace a technology-first philosophy. Desiree Sainthrope, a legal expert specializing in global compliance and intellectual property, joins us to discuss the rise of Antheros, a firm launched in San Francisco in 2025. Founded by three veterans from Goodwin Procter’s IP group, this firm represents a new class of “AI-native” practice that integrates scientific rigor with automated workflows to redefine how intellectual property is managed in the life sciences sector.
We explore the transition from routine patent prosecution to high-level strategic counseling, the specific software ecosystems powering modern patent law, and the structural tension between traditional hourly billing and the rapid speed of generative artificial intelligence tools.
Traditional IP practices often involve extensive rote work, such as drafting specifications and managing prosecution. How does an AI-native approach fundamentally shift the daily life of an attorney compared to the legacy Big Law model?
The shift is akin to moving from manual data entry to high-level system architecture. In a traditional firm, a junior associate or patent agent might spend dozens of hours meticulously drafting technical specifications or responding to routine office actions, often feeling like a cog in a massive billable machine. By adopting an AI-native stance, the team at Antheros can compress that rote work, effectively “buying back” time for their staff of roughly a dozen professionals to engage in the heavy lifting of strategic portfolio management. This freedom allows an attorney to sit down and truly think about where a client’s technology fits into the global market rather than just getting the paperwork through the door. It replaces the exhausting grind of administrative prosecution with a more intellectually stimulating environment where the focus remains on the strategic “why” rather than just the administrative “how.”
Antheros utilizes enterprise AI software from providers like Harvey, LexisNexis, and AnkarAI to create bespoke workflows for things like gap analysis. Could you explain the process of mapping these tools to specific legal tasks and why a “one-size-fits-all” AI solution doesn’t work for IP?
Managing a complex life sciences portfolio requires a surgical precision that a single, generic AI tool simply cannot provide. The firm operates with a dedicated AI work team that meets weekly to audit their toolkit, ensuring they are using the right instrument for the right procedural task. For instance, an office action response might require a specific tool optimized for legal reasoning, whereas a freedom-to-operate evaluation might lean on a system better suited for deep scientific data extraction. If the task is scientific in nature, they might pivot to a different provider than they would for a routine regulatory communication with the U.S. Patent and Trademark Office. This granular approach ensures that the inherent risks of general AI are mitigated by using specialized, enterprise-grade software tailored for discrete buckets of practice, such as patent prosecution or communication with regulators.
The founders of this firm transition from backgrounds in pharmaceutical research, engineering, and biomedical sciences. Why is this technical curiosity so vital when building a law firm that relies heavily on evolving technology?
There is a natural synergy between the scientific method and the development of AI-native legal workflows because both require a deep, inquisitive dive into the “weeds” of a problem. Scientists are trained to be inherently skeptical and experimental, which is exactly the mindset needed to vet new AI tools and integrate them into a practice. When the leadership includes individuals with a Ph.D. in biomedical sciences or a background in medical device engineering, they don’t just see a patent as a legal document; they see it as a technical challenge that demands a precise solution. These attorneys aren’t just adopting software because it’s trendy; they are leveraging their technical fluency to ensure the AI’s output meets the rigorous standards of the life sciences industry. This inherent curiosity allows them to stay ahead of the curve, constantly refining their processes as the technology itself evolves from month to month.
There is often a structural tension between the billable hour and the efficiency gained through AI. How does shifting to subscription-based or flat-fee pricing change the relationship between a law firm and its clients?
The traditional billing structure often creates a “perverse incentive” where efficiency is actually penalized because it reduces the number of hours billed, making it difficult for legacy firms to fully embrace automation. By moving toward subscription-based or flat-fee models, an AI-native firm aligns its interests directly with the client’s desire for speed and quality. This model allows for innovations like instantaneous gap analysis, where AI can evaluate unclaimed subject matter across an entire portfolio of families and pending claims without the client fearing a massive, unexpected invoice. It creates a space where attorneys can focus on knowledge management and business development rather than hitting an arbitrary hourly requirement that often leads to burnout and misaligned goals. Ultimately, it transforms the lawyer from a vendor charging by the minute into a strategic partner who is incentivized to provide the best advice as efficiently as possible.
Despite the speed of AI, the founders emphasize that human expertise remains irreplaceable, especially in highly technical areas. In what specific scenarios would relying solely on AI lead to a poor work product for a life sciences client?
Life sciences IP work is incredibly layered and nuanced; simply feeding an invention disclosure into an AI and expecting a robust patent application is a recipe for disaster. While AI is excellent at summarizing and organizing data, it lacks the depth of knowledge and the “human touch” required for high-level strategic thinking during complex prosecution. You need an attorney who understands the subtle shifts in regulatory landscapes and the long-term commercial goals of a startup to craft a truly defensible portfolio. A machine might miss the strategic importance of a specific chemical variant or fail to anticipate how a competitor might attempt to design around a claim. The sensory and emotional intelligence required to navigate a negotiation or a high-stakes meeting with regulators is something that current generative tools simply cannot replicate, and clients in these fields expect a level of sophistication that only human experience provides.
What is your forecast for the future of “AI-native” firms in specialized sectors like IP?
I expect that within the next five years, the “AI-native” label will become the gold standard for boutiques specializing in high-growth sectors, eventually forcing Big Law to abandon its reliance on the billable hour for routine tasks. We will see a consolidation of talent as top-tier attorneys with technical backgrounds realize they can provide more value and enjoy better work-life balance in leaner, tech-forward environments. The firm of the future won’t just use AI as an add-on; it will hire staff based on their ability to manage AI systems and design its entire revenue model around the value of its strategic insights rather than the volume of its paperwork. As more startups realize they can get portfolio-wide, instantaneous advice through subscription models, the traditional 80-year-old structure of the industry will begin to fade into the background.
